HCM
ASPX

Harvey Capital Management’s AUSPEX PHARMACEUTICALS INC COM STK (DE) ASPX Stock Holding History

Harvey Capital Management’s Portfolio ASPX Stock Details ASPX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-9,750
Closed -$977K – 94
2015
Q1 		$977K Buy
9,750
+3,400
+54% +$226K 0.36% 48
2014
Q4 		$333K Buy
+6,350
New +$186K 0.13% 61

Harvey Capital Management's ASPX Position: Q2 2015 in Review

Harvey Capital Management sold out of AUSPEX PHARMACEUTICALS INC COM STK (DE) (ASPX) in Q2 2015, closing a stake of 9,750 shares — an estimated $977K sold.

Harvey Capital Management first reported a position in ASPX in Q4 2014 and held it in 2 quarters. The position peaked at $977K in Q1 2015. 0 funds tracked by Wall St. Rank hold ASPX as of Q2 2015.

  • Harvey Capital Management reported no remaining AUSPEX PHARMACEUTICALS INC COM STK (DE) position as of Q2 2015 after selling out during the quarter.
  • Harvey Capital Management sold 9,750 AUSPEX PHARMACEUTICALS INC COM STK (DE) shares in Q2 2015, an estimated $977K.
  • Harvey Capital Management first reported a position in AUSPEX PHARMACEUTICALS INC COM STK (DE) in Q4 2014 and held it in 2 quarters.
  • Harvey Capital Management's AUSPEX PHARMACEUTICALS INC COM STK (DE) position peaked at $977K in Q1 2015.
  • 0 funds tracked by Wall St. Rank held AUSPEX PHARMACEUTICALS INC COM STK (DE) as of Q2 2015.

Based on Harvey Capital Management's 13F filing for Q2 2015, filed 22 Jul 2015.